Please wait while we load the requested 10-K report or click the link below:
FOR IMMEDIATE RELEASE
Media Contact Information:
Investor Contact Information:
Grew fourth quarter adjusted earnings per share (EPS) by 7% to $2.12 and full year adjusted EPS by 6% to $7.39.
Increased fourth quarter revenue by 4% to $4.65 billion.
Expanded fourth quarter adjusted operating margin by 40 basis points to 23.2%.
Launched significant new products in 2015 for research, clinical and applied markets, highlighted by the QuantStudio 3 and 5 qPCR systems, Orbitrap Fusion Lumos Tribrid mass spectrometer and the Ion S5 and S5 XL next-generation sequencing instruments.
Leveraged increasing scale in Asia-Pacific and emerging markets to deliver strong growth, led by outstanding performance in China and significant contributions from India and South Korea.
Successfully integrated the Life Technologies acquisition, which strengthened our customer value proposition and accelerated growth.
In 2015, deployed nearly $700 million to expand our bioproduction and laboratory chemicals offerings through acquisitions of Advanced Scientifics, Inc. and Alfa Aesar; also repurchased $500 million of stock.
Reduced debt by approximately $2.0 billion in 2015 and achieved target leverage ratio.
After year end, announced agreement to acquire Affymetrix for $1.3 billion to strengthen leadership in biosciences and genetic analysis.
The following information was filed by Thermo Fisher Scientific Inc. (TMO) on Thursday, January 28, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Thermo Fisher Scientific Inc.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Thermo Fisher Scientific Inc..